Advanced Biomed
(NASDAQ) ADVB
Advanced Biomed Financials at a Glance
Market Cap
$8.84MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Revenue (TTM)
$0.00
Net Income (TTM)
-$677.61K
EPS (TTM)
$0.16
P/E Ratio
33.61
Dividend
$0.00
Beta (Volatility)
0.23 (Low)
Dividend
$0.00
Beta (Volatility)
0.23 (Low)
Price
$5.08
Volume
9,160.793
Open
$5.16
Price
$5.08
Volume
9,160.793
Open
$5.16
Previous Close
$5.04
Daily Range
$5.00 - $5.26
52-Week Range
$3.61 - $18.20
Estimated Earnings Date
May 15, 2025
Dividend
$0.00
Beta (Volatility)
0.23 (Low)
Price
$5.08
Volume
9,160.793
Open
$5.16
Previous Close
$5.04
Daily Range
$5.00 - $5.26
52-Week Range
$3.61 - $18.20
Estimated Earnings Date
May 15, 2025
ADVB News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Advanced Biomed
Industry
Healthcare Equipment and Supplies
Sector
Health CareEmployees
31
CEO
Yi Lu, PhD
Website
www.advanbiomed.comHeadquarters
New York City, NY 10168, US
ADVB Financials
Key Financial Metrics (TTM)
Gross Margin
0.00%
Operating Margin
0.00%
Net Income Margin
0.00%
Return on Equity
-65.06%
Return on Capital
-1.98%
Return on Assets
-203.48%
Earnings Yield
2.98%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$8.84MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Shares Outstanding
1.65M
Volume
9.16K
Avg. Volume
133.74K
Financials (TTM)
Gross Profit
-$2.84K
Operating Income
-$1.10M
EBITDA
-$1.00M
Operating Cash Flow
-$691.70K
Capital Expenditure
-$2.90K
Free Cash Flow
-$694.59K
Cash & ST Invst.
$81.41K
Total Debt
$23.20K
Advanced Biomed Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
-$294.00
N/A
Gross Margin
0.00%
N/A
Market Cap
$8.84MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
N/A
Market Cap/Employee
$285.13K
N/A
Employees
31
N/A
Net Income
-$488.94K
+64.7%
EBITDA
-$479.50K
+9.3%
Quarterly Fundamentals
Total Cash
$81.41K
-47.9%
Total Debt
$23.20K
-87.6%
Accounts Receivable
$3.02K
-53.3%
Inventory
$0.00
N/A
Long Term Debt
$341.04
-99.2%
Short Term Debt
$41.47K
-70.9%
Return on Assets
-2.03%
N/A
Return on Invested Capital
-3.80%
N/A
Free Cash Flow
-$6.93K
+99.8%
Operating Cash Flow
-$6.90K
+99.8%